Mouse model predicts effects of smoking and varenicline on event-related potentials in humans.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nicotine & Tobacco Research

• Publication date

  2010-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/ntr/ntq049PMID 20395358PMCID PMC2878727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect.

  2009cited by this paper
• Multiple motivational forces contribute to nicotine dependence.

  2009cited by this paper
• Varenicline improves mood and cognition during smoking abstinence.

  2009cited by this paper
• Role of β2-containing nicotinic acetylcholine receptors in auditory event-related potentials

  2009cited by this paper
• Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction.

  2008cited by this paper
• Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with Auditory Event-Related Potentials and Prepulse Inhibition of Startle

  2008cited by this paper
• Development of Procedures for Early Screening of Smoking Cessation Medications in Humans

  2008cited by this paper
• Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.

  2008cited by this paper
• Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.

  2008cited by this paper
• Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

  2008cited by this paper
• Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt

  2008cited by this paper
• Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma.

  2007cited by this paper
• Nicotinic control of axon excitability regulates thalamocortical transmission

  2007cited by this paper
• Effects of nicotine vary across two auditory evoked potentials in the mouse.

  2007cited by this paper
• Effects of cigarette smoking on prepulse inhibition, its attentional modulation, and vigilance performance.

  2007cited by this paper
• Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning.

  2007cited by this paper
• Inhibitory gating of single unit activity in amygdala: effects of ketamine, haloperidol, or nicotine.

  2007cited by this paper
• Effects of abstinence from tobacco: valid symptoms and time course.

  2007cited by this paper
• Translational research in medication development for nicotine dependence

  2007cited by this paper
• Human Tobacco Smokers in Early Abstinence Have Higher Levels of β2* Nicotinic Acetylcholine Receptors than Nonsmokers

  2006cited by this paper
• Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence.

  2006cited by this paper
• Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy

  2006cited by this paper
• Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

  2006cited by this paper
• Ketamine Produces Lasting Disruptions in Encoding of Sensory Stimuli

  2006cited by this paper
• Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial

  2006cited by this paper
• Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

  2006cited by this paper
• Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.

  2006cited by this paper
• Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors

  2006cited by this paper
• Medication screening for smoking cessation: a proposal for new methodologies

  2006cited by this paper
• METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO

  2006cited by this paper
• Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro.

  2006cited by this paper
• α4β2 Nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating

  2006cited by this paper
• Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating.

  2006cited by this paper
• Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial

  2006cited by this paper
• Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.

  2005cited by this paper
• Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers.

  2005cited by this paper
• Monoamine Oxidase Inhibition Dramatically Increases the Motivation to Self-Administer Nicotine in Rats

  2005cited by this paper
• Reduced nicotine reward in obesity: cross-comparison in human and mouse

  2005cited by this paper
• Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of α7 nicotinic acetylcholine receptors

  2005cited by this paper
• Effects of Chronic Olanzapine and Haloperidol Differ on the Mouse N1 Auditory Evoked Potential

  2004cited by this paper
• Midlatency auditory event-related potentials in mice: comparison to midlatency auditory ERPs in humans.

  2004cited by this paper
• Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications.

  2004cited by this paper
• Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation.

  2004cited by this paper
• Increased anxiety-like behavior in adult rats exposed to nicotine as adolescents.

  2003cited by this paper
• Effects of tobacco smoking on electroencephalographic, auditory evoked and event related potentials.

  2003cited by this paper
• Nicotine Induces Glutamate Release from Thalamocortical Terminals in Prefrontal Cortex

  2003cited by this paper
• Self-administration of 5-iodo-A-85380, a &bgr;2-selective nicotinic receptor ligand, by operantly trained rats

  2003cited by this paper
• Phase synchronization of the ongoing EEG and auditory EP generation.

  2003cited by this paper
• Effects of Strain, Novelty, and NMDA Blockade on Auditory-Evoked Potentials in Mice

  2003cited by this paper
• Tobacco smoking increases gating of irrelevant and enhances attention to relevant tones.

  2002cited by this paper
• Dynamic Brain Sources of Visual Evoked Responses

  2002cited by this paper
• Enhancement of auditory sensory gating and stimulus-bound gamma band (40 Hz) oscillations in heavy tobacco smokers.

  2002influential reference
• Self-reported abstinence effects in the first month after smoking cessation.

  2001cited by this paper
• The effect of bupropion on nicotine craving and withdrawal

  2000cited by this paper
• Selective alpha 7 nicotinic receptor stimulation normalizes chronic cocaine-induced loss of hippocampal sensory inhibition in C3H mice.

  1999cited by this paper
• Nicotine self-administration in animals as a dependence model.

  1999cited by this paper
• Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice

  1998cited by this paper
• Schizophrenia, sensory gating, and nicotinic receptors.

  1998cited by this paper
• Effects of tobacco smoking and abstinence on middle latency auditory evoked potentials

  1998cited by this paper
• Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats

  1995cited by this paper
• Normalization of auditory physiology by cigarette smoking in schizophrenic patients.

  1993cited by this paper
• Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics.

  1992cited by this paper
• Subcortical and cortical components of the MLR generating system.

  1991cited by this paper
• Spontaneous EEG changes during tobacco abstinence and nicotine substitution in human volunteers.

  1989cited by this paper
• Modulation of the gating of auditory evoked potentials by norepinephrine: pharmacological evidence obtained using a selective neurotoxin.

  1988cited by this paper
• Depth evoked potential and single unit correlates of vertex midlatency auditory evoked responses.

  1983cited by this paper

• Changes in distinct brain systems identified with fMRI during smoking cessation treatment with varenicline: a review

  2024cites this paper
• Alterations of auditory sensory gating in mice with noise-induced tinnitus treated with nicotine and cannabis extract

  2023influential citation
• Unraveling the role of Slc10a4 in auditory processing and sensory motor gating: implications for neuropsychiatric disorders?

  2023cites this paper
• Nicotine receptor partial agonists for smoking cessation

  2023cites this paper
• Nicotine receptor partial agonists for smoking cessation

  2023cites this paper
• Nicotine receptor partial agonists for smoking cessation.

  2016cites this paper
• EEG biomarkers of target engagement, therapeutic effect, and disease process

  2015cites this paper
• The Role of Nicotine in Schizophrenia.

  2015cites this paper
• Baseline dependency of nicotine’s sensory gating actions: similarities and differences in low, medium and high P50 suppressors

  2013cites this paper
• Electroencephalographic and early communicative abnormalities in Brattleboro rats

  2013cites this paper
• Abnormal Pre-Attentive Arousal in Young Children with Autism Spectrum Disorder Contributes to Their Atypical Auditory Behavior: An ERP Study

  2013cites this paper
• Animal models and measures of perceptual processing in schizophrenia.

  2013cites this paper
• The Antinociceptive Effects of Nicotinic Partial Agonists Varenicline and Sazetidine-A in Murine Acute and Tonic Pain Models

  2012cites this paper
• Nicotine Receptor Subtype-Specific Effects on Auditory Evoked Oscillations and Potentials

  2012cites this paper
• The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.

  2011influential citation
• Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

  2011cites this paper
• The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine.

  2011cites this paper